Back to 
RA Capital Management, L.P.
RA Capital Management, L.P.
OCUL
Showing 0 of 7 quarters
Position history for RA Capital Management, L.P.'s holdings in Ocular Therapeutix, Inc.
No. RA Capital Management exited its OCUL (Ocular Therapeutix) position in Q4 2021. Its Q3 2021 13F listed 750,000 shares worth $7.5M. RA Capital Management first reported OCUL in Q2 2020 and held it in 6 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.